Akihiko Koshino

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Fluorescent Probe

Top Venues

Diabetes, obesity & metabolism

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

This page only lists publications with an associated author ORCID identifier.

Publications

Akihiko Koshino, Hiddo J Lambers Heerspink, Niels Jongs, Sunil V Badve, Clare Arnott, Bruce Neal, Meg Jardine, Kenneth W Mahaffey, Carol A Pollock, Vlado Perkovic, Michael K Hansen, Stephan J L Bakker, Takashi Wada, Brendon L Neuen
Canagliflozin and iron metabolism in the CREDENCE trial. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2024)
Akihiko Koshino, Megumi Oshima, Clare Arnott, Robert A Fletcher, George L Bakris, Meg Jardine, Kenneth W Mahaffey, Vlado Perkovic, Carol Pollock, Hiddo J Lambers Heerspink, Brendon L Neuen
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: A post hoc analysis of the CREDENCE trial. Diabetes, obesity & metabolism (2023)
Akihiko Koshino, Megumi Oshima, Clare Arnott, Robert A Fletcher, George L Bakris, Meg Jardine, Kenneth W Mahaffey, Vlado Perkovic, Carol Pollock, Hiddo J Lambers Heerspink, Brendon L Neuen
Effects of canagliflozin on liver steatosis and fibrosis markers in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis of the CREDENCE trial. Diabetes, obesity & metabolism (2023)
Akihiko Koshino, Meir Schechter, Taha Sen, Priya Vart, Brendon L Neuen, Bruce C Neal, Clare Arnott, Vlado Perkovic, Paul M Ridker, Katherine R Tuttle, Michael K Hansen, Hiddo J Lambers Heerspink
Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVAS. Diabetes care 45 (11) (2022)
Taha Sen, Akihiko Koshino, Bruce C Neal, Maarten J Bijlsma, Clare Arnott, Jing-Wei Li, Michael K Hansen, Joachim H Ix, Hiddo J Lambers Heerspink
Mechanisms of action of the sodium-glucose cotransporter-2 (SGLT2) inhibitor canagliflozin on tubular inflammation and damage: A post hoc mediation analysis of the CANVAS trial. Diabetes, obesity & metabolism 24 (10) (2022)